Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer

BACKGROUND: Patients with cancer are more likely to develop nonvalvular atrial fibrillation (NVAF). Currently there are no definitive clinical trials or treatment guidelines for NVAF patients with concurrent cancer. OBJECTIVES: This subgroup analysis of the ARISTOPHANES study compared the risk of st...

Descripción completa

Detalles Bibliográficos
Autores principales: Deitelzweig, Steven, Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin, Lip, Gregory Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463723/
https://www.ncbi.nlm.nih.gov/pubmed/34604802
http://dx.doi.org/10.1016/j.jaccao.2021.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463723/
https://www.ncbi.nlm.nih.gov/pubmed/34604802
http://dx.doi.org/10.1016/j.jaccao.2021.06.004

Ejemplares similares